Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Interesting final two paragraphs in this article from AZ website. They mention the need for a global standardisation of test's to measure the level's of antibodies produced by the vaccines.
https://www.astrazeneca.com/what-science-can-do/topics/disease-understanding/what-does-immunogenicity-mean-in-the-context-of-covid-19-vaccines.html
Then we've learnt that a diagnostics expert from the Immune -Oncology Precision Medicine department at Astra Zeneca has been recruited by Novacyt to take up the role of Clinical Performance Director early in February. This I take as being the job that was advertised to oversee the secretive clinical trial work which Novacyt are involved with at the Blizzard Institute. PS-We never did find out who Novacyts partner was in the lab covid19 antibody test they developed last year.
andrewba
I read that RNS again this morning and had exactly the same thoughts .
Confirmed and suspected cases of reinfection with the virus have been reported, but remain rare.
"It has helped people confirm that the illness they experienced was indeed COVID-19. It also has limitations as some people do not develop IgG antibodies after having COVID-19."
That is true, but what would be the point other than to say you've had covid at some point in the last 12 months. You can still catch it again and be contagious, even with antibodies present, doesn't (or shouldn't) be a deciding factor on whether to get vaccinated, nor should it be used to decide whether to get a yearly booster or not. Antibodies waning? Get your yearly booster. Antibodies ok but likely to fade in next 6 months? Get your yearly booster. Antibody tests are great for chronic illnesses like HIV, not so much for things like covid, all imo.
COVID-19 antibody testing has provided important information to those who have not been able to test for COVID-19 while unwell or tested with PCR too late or early. It has helped people confirm that the illness they experienced was indeed COVID-19. It also has limitations as some people do not develop IgG antibodies after having COVID-19.
Now, COVID-19 antibody testing is being used as a tool to check whether a COVID-19 vaccine has worked to trigger a sufficient immune response. SO the antibody test has become available that not only gives a positive or negative result but also provides a quantitative result, ie. it tells you how many antibodies you have. This test has been referred to as the COVID-19 “vaccine antibody test” in some circles.
I’m fairly confident that the antibody test is being developed hand in glove with AZ so demand is surely there.
@JRDC
I haven't seen any data to suggest what the size of any possible market is for a highly accurate Antibody Test so your point could well be valid. Also, no idea what the price point would be or margin for mass production of this sort of test either.
However, i do see it as an additional product line, something that can add to revenues going forwards on top of all other activity so i see this as a good thing a PLUS if you like.
If it turns out the product is "Next Gen" and better than anything else on the market then logic dictates that some will buy it. Personally i would buy one if it was accurate enough to tell me I had X percentage protection. Most of my family are the same. Ultimately i believe that the Covid jab will be like a constantly updated Flu jab required every so often so a test to know if your current levels are low and need topping up via a vaccine could be a great thing?
We will see.
I think the market will give zero ****s about antibody tests just like the dhsc, esp as it's cheaper just to give another jab. The world is waiting for a decent AN or sakiva lft antigen test, not antibody.
The next key point will be to issue antibody LFT, the sooner the better, otherwise, we gonna miss the point. The market seems to like LFTs for some reason, they are supported by the government and they are even being compared to PCR tests (which is complete nonsense!)
From the last RNS "Research and Development Update"
"Development of the COVID-19 antibody lateral flow test"
"Development of the loop-mediated isothermal amplification COVID-19 test"
Wait and Hold.